Dr. Steve Nissen and Dr. C. Michael Gibson discuss how management is evolving beyond statins alone—highlighting earlier combination therapy, lower LDL-C goals, and expanded roles for non-statin therapy
Sponsored by Esperion Therapeutics Inc., who did not influence the content of the presentation